1. Home >
  2. Exits Navilyst Medical

Investment Summary

Exits Navilyst Medical

On December 13, 2007, invested in healthcare services company Navilyst Medical from Boston Scientific for 425M USD

Investment Highlights
  • This is transaction in the Healthcare Services sector.
  • This is largest (disclosed) transaction.
  • This is transaction in the United States.
Investment Fate
  • Navilyst Medical was sold to a publicly-traded strategic buyer in 2012 for 372M USD.
  • Navilyst Medical was divested to a financial buyer in 2013 for 425M USD.

Investment Summary
Date 2007-12-13
Target Navilyst Medical
Sector Healthcare Services
Sellers(s) Boston Scientific
Deal Type Divestiture
Deal Value 425M USD

Target

Navilyst Medical

Marlborough, United States
Navilyst Medical, Inc. is a provider of innovative solutions for image-guided interventions delivering superior outcomes and reducing healthcare costs for medical professionals and their patients.

Search 204,717 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 2 of 6
Sector (Healthcare Services) 1 of 2
Type (Divestiture) 1 of 1
Country (United States) 2 of 6
Year (2007) 2 of 2
Size (of disclosed) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-05 Boston Scientific - Cardiac Surgery & Vascular Surgery Businesses

United States

Boston Scientific Corp. - Cardiac Surgery & Vascular Surgery Businesses is a developer of medical technologies designed for use in surgical cardiac procedures, including beating-heart bypass surgery systems and endoscopic vessel harvesting for coronary bypass surgery.

Sell $750M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-27 CryoCor

San Diego, California, United States

CryoCor, Inc. is a medical technology company specializing in the use of intracardiac cryotherapy technology.

Buy -
Mergr

Product

Company

Legal